Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients

Trial Early Phase 1 Completed Aug. 6, 2026

Effects of Transcutaneous Vagus Nerve Stimulation in Parkinson´s Disease

Trial N/A Active, not recruiting Aug. 6, 2026

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

Trial Phase 2 Recruiting Aug. 6, 2026

Deep Brain Stimulation Surgery for Movement Disorders

Trial N/A Recruiting Aug. 6, 2026

Psilocybin Therapy for Depression in Parkinson's Disease

Trial Phase 2 Recruiting Aug. 6, 2026

Clinical and Physiological Studies of Tremor Syndromes

Trial N/A Completed Aug. 6, 2026

Studies of Frontal Lobe Brain Functioning in Schizophrenia

Trial N/A Completed Aug. 6, 2026

Deep Brain Stimulation Therapy in Movement Disorders

Trial N/A Recruiting Aug. 6, 2026

Young Onset Parkinson's Disease Subtypes and Pathogenic Mechanisms

Trial N/A Recruiting Aug. 6, 2026

Agricultural Health Study Follow-up

Trial N/A Completed Aug. 6, 2026

Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases

Trial Phase 4 Recruiting Aug. 6, 2026

Autologous Bone Marrow Aspirate (IV) and Bone Marrow Concentrate (Intranasal) for Parkinson's Disease and Parkinson-Plus Syndromes (SPARC-PD)

Trial Phase 1 Active, not recruiting Aug. 6, 2026

User-friendliness of a Portable Driving Simulator

Trial N/A Completed Aug. 6, 2026

Imaging Biomarkers in Parkinson s Disease

Trial N/A Completed Aug. 6, 2026

Blood Pressure Effects on Cognition and Brain Blood Flow in PD

Trial N/A Recruiting Aug. 6, 2026

The Influence of Vibrotactile Stimulation on Self-selected Walking Speed in People With Parkinson's Disease

Trial N/A Completed Aug. 5, 2026

Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease

Trial Phase 2 Recruiting Aug. 5, 2026

An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

Trial Phase 2 Recruiting Aug. 5, 2026

Brain Dopamine Biomarker

Trial N/A Not yet recruiting Aug. 5, 2026

Decoding the Neural Mechanisms Underlying Postural Instability and Gait Dysfunction in Parkinson's Disease

Trial N/A Not yet recruiting Aug. 5, 2026